Monneret G - Search Results

1

Joint modeling of monocyte HLA-DR expression trajectories predicts 28-day mortality in severe SARS-CoV-2 patients.

Baudemont G, Tardivon C, Monneret G, Cour M, Rimmelé T, Garnier L, Yonis H, Richard JC, Coudereau R, Gossez M, Wallet F, Delignette MC, Dailler F, Buisson M, Lukaszewicz AC, Argaud L, Laouenan C, Bertrand J, Venet F; RICO study group. Baudemont G, et al. Among authors: monneret g. CPT Pharmacometrics Syst Pharmacol. 2024 Jul;13(7):1130-1143. doi: 10.1002/psp4.13145. Epub 2024 Jun 5. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38837680 Free PMC article.

2

Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis.

Monneret G, Debard AL, Venet F, Bohe J, Hequet O, Bienvenu J, Lepape A. Monneret G, et al. Crit Care Med. 2003 Jul;31(7):2068-71. doi: 10.1097/01.CCM.0000069345.78884.0F. Crit Care Med. 2003. PMID: 12847405

3

The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration.

Monneret G, Finck ME, Venet F, Debard AL, Bohé J, Bienvenu J, Lepape A. Monneret G, et al. Immunol Lett. 2004 Sep;95(2):193-8. doi: 10.1016/j.imlet.2004.07.009. Immunol Lett. 2004. PMID: 15388260

4

The Th2 response as monitored by CRTH2 or CCR3 expression is severely decreased during septic shock.

Venet F, Lepape A, Debard AL, Bienvenu J, Bohé J, Monneret G. Venet F, et al. Among authors: monneret g. Clin Immunol. 2004 Dec;113(3):278-84. doi: 10.1016/j.clim.2004.07.005. Clin Immunol. 2004. PMID: 15507393

5

Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes.

Venet F, Pachot A, Debard AL, Bohé J, Bienvenu J, Lepape A, Monneret G. Venet F, et al. Among authors: monneret g. Crit Care Med. 2004 Nov;32(11):2329-31. doi: 10.1097/01.ccm.0000145999.42971.4b. Crit Care Med. 2004. PMID: 15640650

6

Both percentage of gammadelta T lymphocytes and CD3 expression are reduced during septic shock.

Venet F, Bohé J, Debard AL, Bienvenu J, Lepape A, Monneret G. Venet F, et al. Among authors: monneret g. Crit Care Med. 2005 Dec;33(12):2836-40. doi: 10.1097/01.ccm.0000189745.66585.ae. Crit Care Med. 2005. PMID: 16352967

7

Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock.

Monneret G, Lepape A, Voirin N, Bohé J, Venet F, Debard AL, Thizy H, Bienvenu J, Gueyffier F, Vanhems P. Monneret G, et al. Intensive Care Med. 2006 Aug;32(8):1175-83. doi: 10.1007/s00134-006-0204-8. Epub 2006 Jun 2. Intensive Care Med. 2006. PMID: 16741700

8

Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism.

Venet F, Pachot A, Debard AL, Bohe J, Bienvenu J, Lepape A, Powell WS, Monneret G. Venet F, et al. Among authors: monneret g. J Immunol. 2006 Nov 1;177(9):6540-7. doi: 10.4049/jimmunol.177.9.6540. J Immunol. 2006. PMID: 17056586

9

Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock.

Venet F, Tissot S, Debard AL, Faudot C, Crampé C, Pachot A, Ayala A, Monneret G. Venet F, et al. Among authors: monneret g. Crit Care Med. 2007 Aug;35(8):1910-7. doi: 10.1097/01.CCM.0000275271.77350.B6. Crit Care Med. 2007. PMID: 17568330

10

Statins and sepsis: do we really need to further decrease monocyte HLA-DR expression to treat septic patients?

Monneret G, Venet F. Monneret G, et al. Lancet Infect Dis. 2007 Nov;7(11):697-9. doi: 10.1016/S1473-3099(07)70245-1. Lancet Infect Dis. 2007. PMID: 17961854 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters